Antibody-mediated protection in murine Cryptococcus neoformans infection is associated with pleotrophic effects on cytokine and leukocyte responses

Infection and Immunity

Volumn 70, Issue 3, 2002, Pages 1571-1580

  Feldmesser, Marta ^a   Mednick, Aron ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 2H1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; COLONY FORMING UNIT; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG MECHANISM; FLUORESCENCE ACTIVATED CELL SORTING; GRANULOMATOUS INFLAMMATION; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LEUKOCYTE; LUNG INFECTION; MACROPHAGE; MENINGOENCEPHALITIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; BACTERIAL CAPSULES; CRYPTOCOCCOSIS; CYTOKINES; LEUKOCYTES; LUNG DISEASES, FUNGAL; MENINGITIS, CRYPTOCOCCAL; MICE;

EID: 0036179288     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.3.1571-1580.2002     Document Type: Article

References (61)

1. A role for B cells in resistance to Cryptococcus neoformans in mice
2. Th1-Th2: Reliable paradigm or dangerous dogma?
3. Human intravenous immunoglobulin modulates monokine production in vitro
4. Pooled human IgG modulates cytokine production in lymphocytes and monocytes
5. Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans
6. Immune complex-induced interleukin-6, interleukin-10 and prostaglandin secretion by human monocytes: A network of pro- and anti-inflammatory cytokines dependent on the antigen: Antibody ratio
7. Differential regulation of immune responses by highly and weakly virulent Cryptococcus neoformans isolates
8. Antibodies to C-C chemokine receptor 5 in normal human IgG block infection of macrophages and lymphocytes with primary R5-tropic strains of HIV-1
9. Characterization of a murine monoclonal antibody to Cryptococcus neoformans polysaccharide that is a candidate for human therapeutic studies
10. Antibodies elicited by a Cryptococcus neoformanstetanus toxoid conjugate vaccine have the same specificity as those elicited in infection
11. Monoclonal antibody based ELISAs for cryptococcal polysaccharide
12. Adjunctive immune therapy for fungal infections
13. Experimental murine pulmonary cryptococcosis. Differences in pulmonary inflammation and lymphocyte recruitment induced by two encapsulated strains of Cryptococcus neoformans
14. The value of cryptococcal serum antigen screening among HIV-positive/AIDS patients in Kinshasa Zaire
15. Cryptococcal polysaccharides bind to CD18 on human neutrophils
16. Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils
17. Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody
18. Intracellular parasitism of macrophages by Cryptococcus neoformans
19. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection
20. Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro
21. Effect of antibody to capsular polysaccharide on eosinophilic pneumonia in murine infection with Cryptococcus neoformans
22. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection
23. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection
24. The role of B7 costimulation in T-cell immunity
25. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells
26. IL-12 and IFN-gamma are required for initiating the protective Th1 response to pulmonary cryptococcosis in resistant C.B-17 mice
27. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice
28. IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6)
29. Macrophage inflammatory protein-1α (MIP-1α) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection
30. Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma-inducing cytokines
31. Interferon-gamma (IFN-gamma)-dependent protection and synthesis of chemoattractants for mononuclear leucocytes caused by IL-12 in the lungs of mice infected with Cryptococcus neoformans
32. Involvement of endogenously synthesized interleukin (IL)-18 in the protective effects of IL-12 against pulmonary infection with Cryptococcus neoformans in mice
33. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: Effects of interleukin-12
34. Cryptococcus neoformans: Intracellular or extracellular?
35. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis
36. TNF-alpha, nitric oxide and IFN-gamma are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii
37. Cryptococcal glucuronoxylomannan induces interleukin (IL)-8 production by human microglia but inhibits neutrophil migration toward IL-8
38. Expression of lung inducible nitric oxide synthase protein does not correlate with nitric oxide production in vivo in a pulmonary immune response against Cryptococcus neoformans
39. Human neutrophil-mediated nonoxidative antifungal activity against Cryptococcus neoformans
40. Killing of Cryptococcus neoformans strains by human neutrophils and monocytes
41. Antibody to capsular polysaccharide enhances the function of neutrophils from patients with AIDS against Cryptococcus neoformans
42. B7 costimulatory ligand regulates development of the T-cell response to Cryptococcus neoformans
43. Experimental cryptococcosis in normal and B-cell-deficient mice
44. Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection
45. Protective murine monoclonal antibodies to Cryptococcus neoformans
46. A comparative study of the in vitro immunomodulatory activity of human intact immunoglobulin (7S IVIG), F(ab′)2 fragments (5S IVIG) and Fc fragments. Evidence for post-transcriptional IL-2 modulation
47. Combined effects of IL-12 and IL-18 on the clinical course and local cytokine production in murine pulmonary infection with Cryptococcus neoformans
48. Constructing polycompetitor cDNAs for quantitative PCR
49. Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils
50. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor
51. Characterization of the biological activity of Cryptococcus infections in surgical pathology. The budding index and carminophilic index
52. Polyclonal immunoglobulins (IVIg) modulate nitric oxide production and microglial functions in vitro via Fc receptors
53. Protective antibody therapy is associated with reduced chemokine transcripts in herpes simplex virus type 1 corneal infection
54. The capsule of Cryptococcus neoformans reduces T-lymphocyte proliferation by reducing phagocytosis, which can be restored with anticapsular antibody
55. Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia
56. Cryptococcus neoformans differently regulates B7-1 (CD80) and B7-2 (CD86) expression on human monocytes
57. Specific antibody to Cryptococcus neoformans alters human leukocyte cytokine synthesis and promotes T-cell proliferation
58. Purified capsular polysaccharide of Cryptococcus neoformans induces interleukin-10 secretion by human monocytes
59. Neutralizing antibodies to granulocyte-macrophage colony-stimulating factor, interleukin-1alpha and interferon-alpha but not other cytokines in human immunoglobulin preparations
60. Interleukin-10 induces macrophage apoptosis and expression of CD16 (FcgammaRIII) whose engagement blocks the cell death programme and facilitates differentiation
61. T cells cooperate with passive antibody to modify Cryptococcus neoformans infection in mice